Editorial  by unknown
EDITORIAL COMMENT
Nuclear Cardiology After
Angioplasty and Stent Placement:
Beyond Sensitivity and Specificity*
Dante E. Manyari, MD, FACC,†
Dennis P. Humen, MD, FACC,‡
Merril Knudtson, MD
Edmonton and Calgary, Alberta, Canada
Despite excellent immediate clinical results and anatomic
improvement of critical coronary artery stenosis, functional
abnormalities have been noted to persist for several days or
weeks after successful percutaneous transluminal coronary
artery balloon angioplasty (PTCA) (1–13). Even without
eventual angiographic restenosis, persistent abnormalities of
wall motion (1,2), myocardial perfusion (3–8) and coronary
blood flow dynamics (9–13) have been reported early after
successful PTCA. The clinical and pathophysiologic signif-
icance of these persistent functional abnormalities have
remained elusive since they were first described more than
15 years ago. Is there light at the end of the tunnel? We will
briefly summarize the extensive nuclear cardiology data as it
relates to the functional abnormalities present early after
PTCA and stent placement, including the study of Kosa et
al. (14) published in this issue of the Journal of the American
College of Cardiology.
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The past. Successful PTCA results in marked anatomic,
physiologic and clinical improvement. Thus, minimal lu-
men coronary artery stenosis, stress-induced myocardial
perfusion and wall motion abnormalities and coronary blood
flow reserve (CFR) all improve significantly with successful
PTCA. In contrast to the immediate clinical improvement,
with resolution of symptoms when complete revasculariza-
tion is achieved, abnormalities of coronary flow, perfusion
and function resolve more gradually in a substantial propor-
tion of patients (1–13). Using rest and exercise radionuclide
ventriculography, persistent wall motion abnormalities in
the vascular territory of the culprit lesion were reported to
persist one day to one month after successful PTCA (1,2).
Regional wall motion abnormalities during exercise were
noted in 12 (29%) of 41 patients studied by DePuey et al.
(1) and in 31 (65%) of 48 patients studied by O’Keefe et al.
(2); yet most patients with persistent early wall motion
abnormalities had widely patent vessels during follow-up
coronary angiography four to 18 months after PTCA. What
are the mechanism(s) of the delayed resolution of wall
motion abnormalities after successful PTCA? Could they
relate to restenosis? Let us examine further the results from
the pooled data of these two studies (1,2). Of the 43 patients
with an abnormal early rest–exercise radionuclide ventricu-
logram, 19 patients (44%) developed late angiographic
restenosis. In contrast, of the 46 patients with a normal early
radionuclide ventriculogram, only 2 (4%) developed late
restenosis. Although data derived from radionuclide ven-
triculography do not offer direct coronary anatomic insights,
they raise the possibility of common mechanisms being
responsible for both the wall motion abnormalities early
after PTCA and late restenosis.
Using stress myocardial perfusion imaging, several inves-
tigators have documented persistently abnormal scans 12 h
to six weeks after successful PTCA in a significant number
of patients without evidence of restenosis during clinical and
angiographic follow-up (3–8). Pooled data of four studies
with adequate angiographic follow-up (3–6) show that
although myocardial perfusion in the territory of the dilated
coronary vessel improved from the pre-PTCA studies, it
remained abnormal in 99 (41%) of 242 patients in studies
performed early after PTCA. During sequential myocardial
perfusion studies (3,7), approximately one-half of patients
with an abnormal scan early after balloon angioplasty had
normal studies at three to 10 months after PTCA. What are
the mechanism(s) for an abnormal stress perfusion scan very
early after successful PTCA? Could they relate to those of
restenosis? Analysis of the pooled data shows that 53 (53%)
of the 99 patients with an “abnormal” early perfusion scan
developed angiographic restenosis during late follow-up at
six to 18 months after PTCA. More remarkably, only 17
(12%) of the 143 patients with a normal early myocardial
perfusion scan subsequently developed angiographic reste-
nosis (3–6). Such results led Wijns, Hardoff and Jain and
colleagues (4–6) to conclude that an abnormal early post-
PTCA perfusion scan was useful in separating groups with
high versus low risk for late restenosis. These data do not
offer pathophysiologic insights but suggest that the mech-
anisms for restenosis may be the same as those responsible
for the slow resolution of perfusion abnormalities after
PTCA.
Similar observations have been made during measure-
ments of CFR before and after PTCA. The CFR improves
immediately after successful and seemingly uneventful
PTCA, but in a significant number of patients it remains
below normal levels (9–13). Again, most patients with
abnormal CFR early after PTCA do not develop clinical or
angiographic restenosis, and in these patients, CFR im-
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proves further with time and normalizes by 3 to 12 months
after PTCA (9,10). What are the mechanisms for subnor-
mal CFR immediately after PTCA? It seems clear that
there is a significant relation between post-PTCA CFR
values and measures of procedural vessel injury such as
residual cross-sectional areas and residual pressure gradients
(10,12). Does abnormal CFR early after PTCA predict the
development of later restenosis? Although a large propor-
tion of patients (40% to 100% in individual studies) have
abnormal CFR soon after PTCA, only ;50% of such
patients develop late restenosis.
The present. A variety of local factors of anatomic and
functional integrity, such as intimal tears, intimal flaps,
plaque rupture, endothelial hemorrhage, mural thrombus,
deposition of fibrin (15) as well as inflammation, recoil and
local spasm (16,17), leading to residual stenosis, may be the
main determinants of the early abnormalities of function,
perfusion and flow after PTCA (10–12,18). The subse-
quent disposition of these local factors as vascular remod-
eling unfolds may determine late restenosis after PTCA
(18,19). Standard visual angiographic assessment of lumen
diameter narrowing is an imprecise and inaccurate method
of quantifying the actual cross-sectional area of a stenosed
vessel; this approach may be even less accurate immediately
after PTCA. However, the residual cross-sectional area,
measured using intravascular ultrasound (19) or digital
quantitative analysis of coronary angiograms (18) immedi-
ately to 24 h after PTCA, appear to predict late restenosis.
Alternatively, other nonlocal factors, such as abnormal
vascular reactivity and autoregulation, cell dysfunction due
to prolonged or repetitive ischemia, reperfusion injury,
diffuse atherosclerosis of large epicardial coronary arteries
and microvascular disease, could modulate the early abnor-
malities after PTCA (1,3,12). The findings of Kosa et al.
(14) suggest that local factors may be the key players
involved in the pathophysiology of the early functional,
perfusion and flow abnormalities noted soon after balloon
angioplasty. These investigators used state-of-the-art
positron emission tomographic (PET) techniques, with
13N-ammonia, to measure coronary blood flow at baseline
and at maximal vasodilation. They found that CFR im-
proved immediately after stent placement to levels compa-
rable to other reference regions. The use of stents, as
opposed to balloon angioplasty alone, is associated with
larger residual cross-sectional areas, owing in part to wall
wrapping of intimal flaps. In addition, stents reduce the
tendency for vascular spasm and recoil. The different re-
sponse of CFR to these two forms of revascularization
suggests that local vascular abnormalities incurred at the
time of mechanical intervention are the determinants of the
early post-PTCA functional, perfusion and blood flow
abnormalities.
The results of the study of Kosa et al. (14) need
interpretation in the context of the patient group chosen
and the study design used. Ideally, the effects of stent
placement on CFR should be studied in patients with
single-vessel coronary artery disease. If adjacent regions are
to be used for control purposes for measurements of blood
flow, they must be supplied by angiographically normal
coronary arteries. Significant coronary artery lesions de-
tected by vascular ultrasound or at autopsy may appear mild
on angiography (18,19). The greater CFR Kosa et al. (14)
found in regions where stents were placed may be explained
by their inclusion of patients with mild disease in coronary
arteries of reference regions. Their reported levels of CFR
are low in both stented and remote vessel areas, in agree-
ment with previous studies (20). In addition, considering
previous studies before and after PTCA, serial measure-
ments of CFR would have been useful to understand the
time-related changes that follow placement of coronary
stents. Despite these limitations, their results agree with the
findings of Haude et al. (21). These investigators measured
myocardial perfusion reserve (MPR), using digital subtrac-
tion coronary angiography, in 25 patients with single-vessel
coronary artery disease involving the left anterior descend-
ing coronary artery and no previous myocardial infarction.
Measurements of MPR were made consecutively during a
single session at baseline, after PTCA and again after stent
placement. They found that although MPR improved, it
remained subnormal after PTCA but normalized immedi-
ately after stent placement. The progressive increase of
MPR at baseline, after PTCA and after stent placement
correlated with a progressively larger vascular lumen and a
more pronounced inhibition of elastic recoil after stent
placement (21).
The future. Before accepting CFR measurements as a
useful tool for the detection of restenosis soon after stent
placement, more information is needed regarding the nor-
mal values of CFR, the individual variability of repeated
measurements, the time course of CFR after stenting and its
relation with other measures of coronary anatomy and
function. Routine stress–rest myocardial perfusion studies,
exercise radionuclide ventriculography and measurements of
CFR soon after coronary interventions have no place in the
care of the individual asymptomatic patient in an attempt to
predict restenosis. In contrast, noninvasive cardiac studies,
including 13N-ammonia PET measurements of CFR, are
useful tools to detect restenosis in symptomatic or asymp-
tomatic patients when used three months or longer after
coronary interventions. Studies performed one day to eight
weeks after PTCA (and possibly stent placement [see later
discussion]) are of dubious clinical relevance, because ab-
normalities may indicate that restenosis is already present or
they may reflect a dilated vessel still undergoing remodeling
and scarring, which ultimately may or may not restenose.
Nevertheless, a normal study in a symptomatic patient is
reassuring even when performed early after coronary inter-
ventions.
Until the problem of restenosis after PTCA and stent
placement is solved, early detection of patients at high risk
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for restenosis is important. In the quest for a solution to this
problem, there continues to be a large number of trials
testing methods to prevent restenosis. The use of myocar-
dial perfusion, wall motion or CFR measurements early
after coronary interventions as surrogate end points for
restenosis in these study groups is an intriguing possibility
that needs to be tested.
Kosa et al. (14) suggest that, unlike the post-PTCA
situation, common noninvasive imaging methods to detect
myocardial ischemia may be useful to detect restenosis early
after stent placement. Before accepting this suggestion,
further studies are necessary to see if early abnormalities of
systolic function and perfusion, similar to those present early
after PTCA, are also present after placement of stents. The
time sequences of wall motion, myocardial perfusion and
coronary blood flow abnormalities after stent placement and
their correlation with other variables of coronary anatomy
and function and with the eventual development of reste-
nosis are some of the specific areas that need to be
investigated. By further defining the similarities and differ-
ences between the vascular and myocardial responses elic-
ited by balloon angioplasty and stent placement, our under-
standing of these two popular and widespread methods for
revascularization will increase.
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